Psychopharmacology in Crisis as Research Funds for New Psychiatric Drugs Diminish

By Daniel Cressy of Nature magazine Many people affected by mental illness are facing a bleak future as drug companies abandon research into the area and other funding providers fail to take up the slack, according to a new report. Produced for the European College of Neuropsychopharmacology (ECNP), the report warns that “research in new treatments for brain disorders is under threat”. [More]

Read the original here:
Psychopharmacology in Crisis as Research Funds for New Psychiatric Drugs Diminish